MD Medical Group to Announce 1H 2015 IFRS Financial Results on 7 September

MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE: MDMG), Russia's leading provider of private women's and children's healthcare, announces that it will publish its financial results under international financial reporting standards ("IFRS") for the six months ended 30 June 2015, on Monday, 7 September 2015.

The Company will host a conference call and webcast for investors and analysts on the same day at 5.00 pm Moscow time (3.00 pm London; 10.00 am New York).

MD Medical Group will be represented by:

• Dr. Mark Kurtser, Chairman of the Board of Directors
• Dr. Elena Mladova, Chief Executive Officer
• Vitaly Ustimenko, Chief Financial Officer
• Elena Romanova, Head of IR Department

The press-release, the presentation and the financial statements will be available prior to the conference call on the Company’s website: {root}reports/financialreports/

The dial-in and online viewing details are below:

Webcast-Link: https://engage.vevent.com/rt/deutschebank/index.jsp?seid=83

Conference-call details:

• Russian Federation Free Call: 8 800 775 68 18
• United Kingdom Free Call: 0800 694 02 57
• United States Free Call: 163 151 07 498
• Participant Std International Dial-In: 44 (0) 1452 555566

Access Code: 28736810

Please note that this call is only intended for investors and analysts.

For further information please contact:

Elena Romanova
MD Medical Group Investments Plc
Tel: +7 495 331 4120
e.romanova@mcclinics.ru

About MD Medical Group

MD Medical Group operates in the highly attractive Russian private healthcare service market and has a leading position in high-quality women's health and paediatrics. The company manages 23 modern healthcare facilities, including four hospitals and 19 outpatient clinics in Moscow, St. Petersburg, Ufa, Perm, Samara and Samara region, Novosibirsk, Irkutsk, Yaroslavl and Ryazan. In addition, three franchised outpatient clinics operate in Kyiv, Ukraine.

In 2014, 4,550 deliveries took place at the Company’s facilities; IVF cycles amounted to 7,654. The number of outpatient treatments totalled 818,636 and the number of in-patient days reached 35,900.

The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.